Search

everythinglearnresearchcommunity

for

Search:↓

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

JAK inhibitors show promise for treating various skin diseases.

Macrophage-stimulating protein helps hair grow and can start hair growth phase in mice and human hair samples.

Decorin, a protein, may help start hair growth and could be used to treat hair loss.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Targeted cancer therapies often cause serious skin problems that need careful management.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Epidermal stem cells are diverse and vary in activity, playing key roles in skin maintenance and repair.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

Growth factors are crucial for hair development and could help treat hair diseases.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Beta-caryophyllene, found in essential oils, helps wounds heal better in multiple ways.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.